AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

TechFinancials Inc.

Earnings Release Jul 29, 2022

10338_rns_2022-07-29_5d2a097d-e8a0-4878-9f50-2fa7dd8c7f2d.html

Earnings Release

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 3242U

TechFinancials Inc.

29 July 2022

TechFinancials, Inc

("TechFinancials" or the "Company")

29 July 2022

Audited Annual Report for the year ended 31 December 2021

Financial Highlights

·   No Revenues in 2021 following cessation of operations.

·   Pre-tax loss attributable to shareholders of US$0.553 million (2020: profit of US$1.0   million)

·   Cash position of US$0.92 million as at 31 December 2021 (2020: US$1.4 million)

·   Basic earnings per share ('EPS') (US$0.0064) (2020: (US$0.016))

·   In October 2021, the Company's sold its subsidiary Cedex Holdings Limited ("Cedex")

·   In June 2021, the Company stuck off Footies Ltd. ("Footies)

·   In 2021, the Company acquired shares to take minority holdings in a number of companies listed on the LSE and AIM

Operational Highlights 

Operational Cost Reduction

·   The Company decided to close all its subsidiaries and initiated the strike-off of its entities in Israel in 2021. The strike off of both TechFinancials Israel 2014 Ltd and Softbox Technologies Ltd was initiated in H2 2021 and concluded in March 2022.

·   The Company sold Cedex Holdings Limited in October 2021.

Investment  Activities

·   The Company invested small amounts in several listed entities in 2021. This activity resulted in profit of $86k.

·   As of today, the Company has only one legal entity - TechFinancials Inc, and as results the costs of operating the company is now minimal.

·   In November 2020, the Company signed with RenewSenses Ltd., an Israeli start-up, a Simple Agreement for Future Equity ("SAFE") following which the Company invested in RenewSenses a total amount of US$ 152k. This was accounted for as a financial asset through profit and loss.

As of December 31, 2021, RenewSenses has failed to raise additional capital for its operations and in the beginning of 2022, it was forced to make all employees redundant. As a result of the conditions that existed at year end (inability of raise funds), the financial asset fair valued was revalued to a nil balance and a total loss of $152k recognized.

Chairman's Statement

2021 was a year in which the Company focused on reducing costs and consolidating its assets. We initiated the closure of all our subsidiaries and sold Cedex.

The Board decided to invest some amounts in listed companies and was able to generate good returns from these investments. The Company will continue to look for new ways to increase its value.

Dividends

The Board will not be recommending a final dividend to the shareholders of the Company for the year ended 2021 (2020: $nil).

Outlook and current trading

The year was a turning point for the Group, where we initiated the closure of all our subsidiaries and consolidated all our assets, while seeking new investment opportunities to increase the value of the Company.

The Group will continue to look for investment opportunities to maximize the Company's value, leveraging its available cash.

I would like to thank our shareholders for their continued support in what has been a difficult year.

We look forward to updating the market on our progress in due course.

Eitan Yanuv

Independent Non-Executive Chairman

29 July 2022

The directors of the Company accept responsibility for the contents of this announcement.

For further information:

TechFinancials, Inc. Tel: +972 54 5233 943
Asaf Lahav, Executive Director
Eitan Yanuv, Non-Executive Chairman
Peterhouse Capital Limited (Aquis Stock Exchange Advisor and            Broker) Tel: +44 (0) 20 7469 0930
Guy Miller and Mark Anwyl

Consolidated Statement of Comprehensive Income

For the year ended 31 December 2021

2021 2020
US$'000 US$'000
Revenue - 619
Cost of sales - (35)
Gross profit - 584
Expenses:
Research and development - (384)
Selling and marketing - (33)
Administrative (233) (207)
Impairment of goodwill - -
(233) (624)
Operating (Loss) Income (233) (40)
Bank fees (9) (20)
Foreign exchange income (loss) (30) -
Profit on disposal of traded securities 86 -
Financing income (expenses 47 (60)
Other Income (expenses)
Other non-operational income/ (expenses) - 441
Impairment loss on the financial asset held at FVTPL (152) -
(Loss)/ Profit before taxation (338) 381
Taxation (4) 70
(Loss) / Profit for the year from continuing operations (342) 451
Gain (loss) from discontinued operations (181) 566
Capital loss from a sale of subsidiary ____________________(30) ____________________-
(Loss) / Gain for the year from discontinued operations, net (211) 566
Other comprehensive income - -
Total comprehensive Income (553) 1,017
(Loss) / Profit attributeable to:
Owners of the Company (553) 997
Non-controlling interest - 20
Profit (Loss) for the period (553) 1,017
2021 2020
Cents USD Cents USD
Basic                                                    17 (0.64) 1.16
Diluted N/A 1.16
From continuing operations - Basic (0.40) 0.50
From continuing operations - Diluted N/A 0.50
From discontinued operations - Basic (0.24) 0.66
From discontinued operations - Diluted N/A 0.66

Consolidated Statement of Financial Position

As at 31 December 2021

31 December 31 December
2021 2020
US$'000 US$'000
Non-current assets
Financial asset held at FVPL - 152
- 152
Current assets
Trade receivables, net and other receivables - 13
Short-term investments 26 -
Cash 920 1,419
946 1,432
Total Assets 946 1,584
Current liabilities
Trade and other payables 89 88
Income tax payable - 86
89 174
Non-current liabilities
Shareholders loan 84 84
Equity
Share capital 61 61
Share premium account 12,022 12,022
Share-based payment reserve 798 798
Accumulated profits / (losses) (12,108) (11,555)
Equity attributable to owners of the Company 773 1,326
Total Equity and Liabilities 946 1,584

The Financial Statements were approved by the Board of Directors and authorised for issue on 29 July 2022 and are signed on its behalf by:

…………………………………………

Director

Consolidated statements of changes in equity

For the year ended 31 December 2021

Share capital

(Note 14)
Share

Premium

(Note 14)
Share based payment reserve

(Note, 15)
Revaluation reserve

(Note, 9)
Accumulated profits/

(losses)
Total Non -controlling interests

(Notes 18)
Total
US$'000 US$'000 US$'000 US$'000 US$'000 US$'000 US$'000 US$'000
Balance at 1 January 2020 61 12,022 934 (12,459) 588 (249) 309
Total comprehensive income (expense) for the year - - - - 997 997 20 1,017
Gain on revaluation of cryptocurrency digital assets in the year - - - 577 577 577
Disposal of cryptocurrency digital assets in the year - - - (577) (577) (577)
Purchase of NCI in Footies during the year - - - - (229) (229) 229 -
Share based payment - - 6 (6) - - -
Transfer of Share based payment reserve on lapsed options - - (142) 142 - - -
Balance at 31 December 2020 61 12,022 798 - (11,555) 1,326 - 1,326
Total comprehensive income for the year - - - - (553) (553) (553)
Balance at 31 December 2021 61 12,022 798 - (12,108) 773 - 773

Consolidated statements of cash flows

For the year ended 31 December 2021

The consolidated statements of cash flows for the Group for the years ended 31 December 2021 are set out below: Years ended 31 December
2021 2020
US$'000 US$'000
Cash Flows from operating activities
(Loss) / Profit before tax period (549) 946
Adjustment for:
Amortisation of intangible assets - 75
Impairment of intangible assets, net - 37
Gain on bargain purchase (309)
Depreciation of property and equipment - 4
Profit on disposal of traded securities (86) -
Share option charge - 6
Foreign exchange differences 82 (70)
Waiver of loan due to NCI - (51)
Loss on disposal of subsidiary 30 -
Capital loss on disposal of property and equipment - 12
Gain from revaluation of intangible assets - (577)
Impairment of investment 152 -
Operating cash flows before movements in working capital:
Decrease in trade and other receivables 13 589
Increase (decrease in trade and other payables 48 (1,445)
R&D tax credit received - 163
Income tax paid (93) (109)
Net cash used for operating activities (403) (729)
Cash flows from investing activities
Decrease in restricted bank deposits - (71)
Consideration from sale of intangible assets - 974
Net cash acquired on acquisition (note A) - 649
Net cash on disposal of a subsidiary (75) -
Purchase of traded securities (102) -
Sale of traded securities 163 -
Funds advanced under SAFE agreement - (152)
Net cash generated from (used in) investing activities (14) 1,400
Net increase (decrease) in cash and cash equivalents (417) 671
Cash and equivalents at beginning of period 1,419 672
(Effect of changes in exchange rates on Cash (82) 76
Cash and equivalents at end of period 920 1,419

The comparative cashflow has been restated to correct the allocation of cashflow movements.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXEKLFLLDLLBBD

Talk to a Data Expert

Have a question? We'll get back to you promptly.